Boric Acid

Boric Acid

SCHEMBL6314068

Cc1ccccc1N1CCOCC1.OB(O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.65
ADRB1 P08588 1/20 0.53
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
SLC6A5 Q9Y345 1/20 0.49
LMNA P02545 2/20 0.48
NSD2 O96028 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
TSHR P16473 1/20 0.47
MCOLN3 Q8TDD5 1/20 0.47
POLB P06746 2/20 0.47
PRKDC P78527 1/20 0.46
SLC18A3 Q16572 1/20 0.45
NCF1 P14598 1/20 0.45
CYP2A13 Q16696 1/20 0.45
CNR2 P34972 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1450530 0.93 AKR1C3 (0.68) AKR1C3ADRB1ALOX15HSD17B10SLC6A5
Ammonia Solution, Strong SCHEMBL28721079 0.91 AKR1C3 (0.66) AKR1C3ADRB1ALOX15HSD17B10SLC6A5
SCHEMBL3436629 0.86 AKR1C3 (0.60) AKR1C3ADRB1ALOX15HSD17B10SLC6A5
SCHEMBL29953074 0.81 HSD17B10 (0.49) AKR1C3ALOX15HSD17B10LMNANSD2
SCHEMBL19533 0.81 HSD17B10 (0.49) AKR1C3ALOX15HSD17B10LMNANSD2
SCHEMBL3436474 0.79 AKR1C3 (0.61) AKR1C3ADRB1ALDH1A1CYP2A13KMT2A
SCHEMBL3436453 0.79 AKR1C3 (1.00) AKR1C3HSD17B10SLC6A5LMNAALDH1A1
SCHEMBL28792769 0.79 HTR7 (0.65) AKR1C3ADRB1ALOX15HSD17B10LMNA
SCHEMBL9424119 0.78 LMNA (0.62) AKR1C3ALOX15HSD17B10LMNAL3MBTL1
SCHEMBL4291189 0.78 ADRB1 (0.72) AKR1C3ADRB1LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014810-A1 Use of substituted 2 phenylbenzimidazoles as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014810-A1 Use of substituted 2 phenylbenzimidazoles as medicaments GLP1R, GIPR, GCGR AKR1C3 657/4885ADRB1 61/4885ALOX15 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.